Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: A study by the national cancer institute organ dysfunction working group

Ramesh K. Ramanathan, Merrill J. Egorin, Chris H.M. Takimoto, Scot C. Remick, James H. Doroshow, Patricia A. LoRusso, Daniel L. Mulkerin, Jean L. Grem, Anne Hamilton, Anthony J. Murgo, Douglas M. Potter, Chandra P. Belani, Michael J. Hayes, Bin Peng, S. Percy Ivy

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: A study by the national cancer institute organ dysfunction working group'. Together they form a unique fingerprint.

Medicine & Life Sciences